TWI718254B - Compound having perovskite structure and light emitting material - Google Patents

Compound having perovskite structure and light emitting material Download PDF

Info

Publication number
TWI718254B
TWI718254B TW106105503A TW106105503A TWI718254B TW I718254 B TWI718254 B TW I718254B TW 106105503 A TW106105503 A TW 106105503A TW 106105503 A TW106105503 A TW 106105503A TW I718254 B TWI718254 B TW I718254B
Authority
TW
Taiwan
Prior art keywords
ion
compound
aforementioned
ions
perovskite
Prior art date
Application number
TW106105503A
Other languages
Chinese (zh)
Other versions
TW201739753A (en
Inventor
内藤翔太
江良正直
Original Assignee
日商住友化學股份有限公司
國立大學法人佐賀大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商住友化學股份有限公司, 國立大學法人佐賀大學 filed Critical 日商住友化學股份有限公司
Publication of TW201739753A publication Critical patent/TW201739753A/en
Application granted granted Critical
Publication of TWI718254B publication Critical patent/TWI718254B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/62Quaternary ammonium compounds
    • C07C211/63Quaternary ammonium compounds having quaternised nitrogen atoms bound to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/61Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing fluorine, chlorine, bromine, iodine or unspecified halogen elements
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/66Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing germanium, tin or lead
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01GCOMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G21/00Compounds of lead
    • C01G21/16Halides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/24Lead compounds

Abstract

To provide a compound having a perovskite structure with a high light emitting intensity and an light emitting material containing the compound. The compound contains a perovskite-type crystal structure having each of A, B, X and M as a component, and a molar ratio [M/(M+B)], the amount of M divided by the total amount of M and B, is 0.7 or less. (A is a monovalent cation locating at each apex of a hexahedron the center of which is B in the perovskite-type crystal structure. B is a lead ion. M is a divalent or trivalent metal ion substituting a part of B in the perovskite-type crystal structure, and a cation selected from among metal ions the 6-coordinated ionic radius of which is 0.9 Å to 1.5 Å. X represents a component locating at each apex of an octahedron the center of wich is B in the perovskite-type crystal structure, and one or more kinds of ions selected from the group consisting of Cl-, Br-, F-, I- and SCN-, and the perovskite-type crystal structure at least contains a chloride ion or a bromide ion as X.)

Description

具有鈣鈦礦結構之化合物及發光材料 Compounds with perovskite structure and luminescent materials

本發明係關於化合物及發光材料。 The present invention relates to compounds and luminescent materials.

本案係依據2016年2月19日於日本申請之日本特願2016-30201號及2016年6月24日於日本申請之日本特願2016-126043號主張優先權,並於本說明書中援用其內容。 This case is based on Japanese Patent Application No. 2016-30201 filed in Japan on February 19, 2016 and Japanese Patent Application No. 2016-126043 filed in Japan on June 24, 2016, and its content is used in this specification. .

既往以來,已知有機-無機鈣鈦礦AMX3化合物,其包含有機物之陽離子(A)、鹵化物離子(X)、及2價金屬離子(M)。近年來,對於具有於金屬離子之位置(M)有IV族元素(Ge、Sn、及Pb)離子之鈣鈦礦結構之化合物的導電性及發光特性之關心度提高。 In the past, organic-inorganic perovskite AMX 3 compounds are known, which include organic cations (A), halide ions (X), and divalent metal ions (M). In recent years, there has been increased interest in the conductivity and luminescence characteristics of compounds having a perovskite structure with ions of group IV elements (Ge, Sn, and Pb) at the position (M) of metal ions.

尤其前述2價金屬離子為Pb(II)時,在紫外線區域至紅色光譜區域之範圍,觀察到於室溫之強烈發光現象(非專利文獻1)。又,藉由鹵化物離子(X)之種類亦可調整發光波長(非專利文獻2)。 In particular, when the aforementioned divalent metal ion is Pb(II), a strong luminescence phenomenon at room temperature is observed in the range from the ultraviolet region to the red spectral region (Non-Patent Document 1). In addition, the emission wavelength can also be adjusted by the type of halide ion (X) (Non-Patent Document 2).

[先前技術文獻] [Prior Technical Literature] [非專利文獻] [Non-Patent Literature]

[非專利文獻1]M.Era, A.Shimizu and M.Nagano, Rep. Prog.Polym.Phys.Jpn., 42,473-474(1999) [Non-Patent Document 1] M. Era, A. Shimizu and M. Nagano, Rep. Prog.Polym.Phys.Jpn., 42,473-474(1999)

[非專利文獻2] L. Protesescu, S. Yakunin, M.I. Bodnarchuk, F. Krieg, R. Caputo,C. H. Hendon, R. X. Yang, A. Walsh, and M. V. Kovalenko, Nano Letter. 15, 3692-3696 (2015) [Non-Patent Document 2] L. Protesescu, S. Yakunin, M.I. Bodnarchuk, F. Krieg, R. Caputo, C. H. Hendon, R. X. Yang, A. Walsh, and M. V. Kovalenko, Nano Letter. 15, 3692-3696 (2015)

然而,將如上述非專利文獻1或2所記載之具有鈣鈦礦結構之化合物作為發光材料進行產業應用時,前述化合物之發光強度被要求進一步提升。 However, when a compound having a perovskite structure as described in Non-Patent Document 1 or 2 is used as a luminescent material for industrial application, the luminous intensity of the aforementioned compound is required to be further improved.

本發明係有鑑於上述課題而成者,且係以提供當作為發光材料使用時有高發光強度之具有鈣鈦礦結構之化合物及含有前述化合物之發光材料為目的。 The present invention was made in view of the above-mentioned problems, and aims to provide a compound having a perovskite structure with high luminous intensity when used as a luminescent material, and a luminescent material containing the aforementioned compound.

為了解決上述課題,本發明人等精心檢討之結果,完成以下之本發明。 In order to solve the above-mentioned problems, the inventors of the present invention, as a result of careful examination, completed the following invention.

亦即,本發明之實施態樣包含下述[1]至[6]之發明。 That is, the implementation aspects of the present invention include the following inventions [1] to [6].

[1]一種具有鈣鈦礦型結晶結構之化合物,其係以A、B、X、及M為成分,且將M之量除以M及B之合計量之莫耳比[M/(M+B)]之值為0.7以下。(A係在前述鈣鈦礦型結晶結構中,位於以B為中心之6面體之各頂點之1價陽離子。 [1] A compound with a perovskite crystal structure, which is composed of A, B, X, and M, and the amount of M is divided by the total molar ratio of M and B [M/(M The value of +B)] is 0.7 or less. (A is a monovalent cation located at each vertex of a hexahedron centered on B in the aforementioned perovskite crystal structure.

B係鉛離子。 B series lead ion.

M係2價或3價金屬離子,且係選自在6配位之離子半徑為0.9Å以上1.5Å以下之金屬離子之陽離子,並且M之至少一部分係在前述鈣鈦礦型結晶結構中,取代B之一部分。 M is a divalent or trivalent metal ion, and is a cation selected from metal ions with an ion radius of 0.9 Å or more and 1.5 Å or less in 6 coordination, and at least a part of M is in the aforementioned perovskite crystal structure, substituted Part B.

X係表示在前述鈣鈦礦型結晶結構中,位於以B為中心之8面體之各頂點之成分,且係選自由氯化物離子、溴化物離子、氟化物離子、碘化物離子及硫氰酸根離子所成之群組之1種以上之離子,並且至少含有氯化物離子或溴化物離子作為前述X) X represents the component located at each vertex of the octahedron centered on B in the aforementioned perovskite crystal structure, and is selected from chloride ion, bromide ion, fluoride ion, iodide ion and thiocyanate One or more ions in the group of acid radical ions, and at least chloride ions or bromide ions are included as the aforementioned X)

[2]如[1]所述之化合物,其係下述通式(1)所示者。 [2] The compound according to [1], which is represented by the following general formula (1).

AB(1-a)MaX(3+δ)(0<a≦0.7,0≦δ≦0.7)...(1)(A、B、M、及X係表示與前述相同意義) AB (1-a) M a X (3+δ) (0<a≦0.7, 0≦δ≦0.7). . . (1) (A, B, M, and X series have the same meaning as the above)

[3]如[1]或[2]所述之化合物,其中,前述M係鹼土金屬之離子。 [3] The compound according to [1] or [2], wherein the M is an ion of an alkaline earth metal.

[4]如[3]所述之化合物,其中,前述M係鈣離子。 [4] The compound according to [3], wherein the M-based calcium ion.

[5]如[1]至[4]中任一項所述之化合物,其中,前述A係有機銨離子。 [5] The compound according to any one of [1] to [4], wherein the aforementioned A-based organic ammonium ion.

[6]一種發光材料,其係含有[1]至[5]中任一項所述之化合物。 [6] A luminescent material containing the compound described in any one of [1] to [5].

依據本發明,可提供發光強度高之具有鈣鈦礦結構之化合物及含有前述化合物之發光材料。 According to the present invention, a compound having a perovskite structure with high luminous intensity and a luminescent material containing the aforementioned compound can be provided.

以下,表示實施形態以詳細說明本發明。 Hereinafter, embodiments are shown to explain the present invention in detail.

<化合物> <Compound> ≪第1實施形態≫ ≪First Embodiment≫

本實施形態之化合物之第1實施形態係具有鈣鈦礦型結晶結構之化合物,其係以A、B、X、及M為成分,且將M之量除以M及B之合計量所得之莫耳比[M/(M+B)]之值為0.7以下。 The first embodiment of the compound of this embodiment is a compound having a perovskite crystal structure, which is obtained by dividing the amount of M by the total amount of M and B with A, B, X, and M as components The value of the molar ratio [M/(M+B)] is 0.7 or less.

本實施形態中,A係在前述鈣鈦礦型結晶結構中,位於以B為中心之6面體之各頂點之1價陽離子。 In this embodiment, A is a monovalent cation located at each vertex of a hexahedron centered on B in the aforementioned perovskite crystal structure.

B係Pb離子。 B is Pb ion.

M係2價或3價金屬離子,且係選自在6配位之離子半徑為0.9Å以上1.5Å以下之金屬離子之陽離子,並且M之至少一部分在前述鈣鈦礦型結晶結構中,取代B之一部分。 M is a divalent or trivalent metal ion, and is a cation selected from metal ions with an ion radius of 0.9 Å or more and 1.5 Å or less in 6 coordination, and at least a part of M is in the aforementioned perovskite crystal structure, replacing B Part of it.

X係表示在前述鈣鈦礦型結晶結構中,位於以B為中心之8面體之各頂點之成分,且係選自由氯化物離子、溴化物離子、氟化物離子、碘化物離子及硫氰酸根離子所成之群組之1種以上之離子。惟,至少含有氯化物離子或溴化物離子作為X。此外,在此,當設為1Å=0.1nm(以下相同)時,M在6配位之離子半徑為0.09nm以上0.15以下。 X represents the component located at each vertex of the octahedron centered on B in the aforementioned perovskite crystal structure, and is selected from chloride ion, bromide ion, fluoride ion, iodide ion and thiocyanate One or more ions in the group formed by acid radical ions. However, it contains at least chloride ion or bromide ion as X. In addition, here, when 1 Å=0.1 nm (the same applies to the following), the ionic radius of the 6 coordination of M is 0.09 nm or more and 0.15 or less.

通常,具有鈣鈦礦型結晶結構之化合物之基本結構係3維結構或2維結構。 Generally, the basic structure of a compound having a perovskite crystal structure is a three-dimensional structure or a two-dimensional structure.

前述基本結構為3維結構時,以A’B’X’3表示。 在此,A’係表示有機陽離子或無機陽離子,B’係表示金屬陽離子,X’係表示鹵化物離子或硫氰酸根離子。 When the basic structure of a 3-dimensional structure to A'B'X '3 represents. Here, A'series means an organic cation or an inorganic cation, B'series means a metal cation, and X'series means a halide ion or a thiocyanate ion.

前述基本結構為2維結構時,以A’2B’X’4表示。在此,A’、B’及X’係表示與前述相同意義。 When the structure is a substantially two-dimensional structure, to A '2 B'X' 4 Fig. Here, A', B', and X'have the same meaning as described above.

前述基本結構為上述3維結構或2維結構時,具有以B’為中心且將頂點設為X’之B’X’6所示之共用頂點之八面體之三維網絡。 When the aforementioned basic structure is the aforementioned three-dimensional structure or two-dimensional structure, it has a three-dimensional network of octahedrons with common vertices shown by B'X' 6 with B'as the center and vertices of X'.

B’係可採用X’之八面體配位之金屬陽離子。 B'is a metal cation that can adopt the octahedral coordination of X'.

A’係位於以B’為中心之六面體之各頂點。 A'is located at each vertex of the hexahedron centered on B'.

本實施形態中,就以A、B、X、及M為成分之具有鈣鈦礦型結晶結構之化合物而言,無特別限定,可為具有前述基本結構為3維結構、2維結構、準2維結構(quasi-two-dimensional structure)之任一結構之化合物。 In this embodiment, the compound having a perovskite-type crystal structure containing A, B, X, and M as components is not particularly limited, and it may have the aforementioned basic structure of three-dimensional structure, two-dimensional structure, and quasi-structure. A compound of any structure of the quasi-two-dimensional structure.

前述基本結構為3維結構時,鈣鈦礦型結晶結構係以AB(1-a)MaX(3+δ)表示。 When the aforementioned basic structure is a three-dimensional structure, the perovskite crystal structure is represented by AB (1-a) M a X (3+δ) .

前述基本結構為2維結構時,鈣鈦礦型結晶結構係以A2B(1-a)MaX(4+δ)表示。 When the structure is a substantially two-dimensional structure, a perovskite-type crystal structure based M a X (4 + δ) expressed as A 2 B (1-a) .

在此,前述a係表示前述莫耳比[M/(M+B)]。 Here, the aforementioned a represents the aforementioned molar ratio [M/(M+B)].

前述δ係可因應B及M之電荷平衡而適當地變更之數,較佳係0以上0.7以下。例如,A為1價陽離子、B為2價陰離子(Pb離子)、M為2價或3價陰離子(金屬離子)及X為1價陰離子(選自由氯化物離子、溴化物離子、氟化物離子、碘化物離子及硫氰酸根離子所成之群組之1種以上之離子)時,能以使前述化合物成為中性(電荷為0)之方 式選擇δ。 The aforementioned δ is a number that can be appropriately changed according to the charge balance of B and M, and is preferably 0 or more and 0.7 or less. For example, A is a monovalent cation, B is a divalent anion (Pb ion), M is a divalent or trivalent anion (metal ion), and X is a monovalent anion (selected from chloride ion, bromide ion, fluoride ion) , Iodide ion and thiocyanate ion form more than one type of ion), the aforementioned compound can be made neutral (the charge is 0) The formula chooses δ.

本實施形態中,發現在具有鈣鈦礦型結晶結構之化合物中,將B’成分之金屬陽離子設為Pb離子(B成分),複數個Pb離子(B成分)之一部分設為M成分,並藉以屬於2價或3價金屬離子且選自在6配位之離子半徑為0.9Å以上1.5Å以下之金屬離子之陽離子取代,藉此可提升前述化合物之發光強度。 In this embodiment, it is found that in a compound having a perovskite crystal structure, the metal cation of the B'component is set as the Pb ion (the B component), and a part of the plural Pb ions (the B component) is set as the M component, and By substituting divalent or trivalent metal ions with cations selected from metal ions with an ion radius of 0.9 Å or more and 1.5 Å or less in 6 coordination, the luminous intensity of the aforementioned compounds can be improved.

本實施形態之具有鈣鈦礦型結晶結構之化合物中之M之至少一部分係意指取代B所示之鉛離子之一部分之成分。 At least a part of M in the compound having a perovskite crystal structure in this embodiment means a component that replaces a part of the lead ion shown by B.

本實施形態之化合物,在前述基本結構中,M可存在於B成分(鉛離子)存在之位置,亦可存在於A成分存在之位置,亦可存在於構成基本結構之骨架之格子間隙。 In the compound of this embodiment, in the aforementioned basic structure, M may exist in the position where the B component (lead ion) exists, may also exist in the position where the A component exists, and may also exist in the lattice gaps constituting the skeleton of the basic structure.

本實施形態中之具有以A、B、X、及M為成分之鈣鈦礦型之結晶結構之化合物係於後述說明。 The compound having a perovskite-type crystal structure with A, B, X, and M as components in this embodiment will be described later.

本實施形態中,鈣鈦礦型結晶結構係指例如當將化合物以X射線繞射(XRD,Cu K α線,X’pert PRO MPD,Spectris公司製)之手段計測時,為3維結構之鈣鈦礦化合物:AB(1-a)MaX(3+δ)之情形,通常係在2 θ=12至18°之位置存在(hkl)=(001)之峰值、或在2 θ=18至25°之位置存在源自(hkl)=(100)之峰值之化合物,較佳係在2 θ=13至16°之位置存在(hkl)=(001)之峰值、或在2 θ=20至23°之位置存在源自(hkl)=(100)之峰值之化合物, 為2維結構之鈣鈦礦化合物:A2B(1-a)MaX(4+δ)之情形,通常係在2 θ=1至10°之位置存在源自(hkl)=(002)之峰值之化合物,較佳係在2 θ=2至8°之位置存在源自(hkl)=(002)之峰值之化合物。 In the present embodiment, the perovskite crystal structure refers to a three-dimensional structure when the compound is measured by means of X-ray diffraction (XRD, Cu K α line, X'pert PRO MPD, manufactured by Spectris), for example. perovskite compound: case of AB (1-a) M a X (3 + δ) , the present system typically = (001) peak of the (hkl), or at 2 θ 2 θ = 12 is the position of = to 18 ° There is a compound derived from the peak of (hkl)=(100) at the position of 18 to 25°, preferably the peak of (hkl)=(001) exists at the position of 2 θ=13 to 16°, or the peak of (hkl)=(001) exists at the position of 2 θ= compound peak values (hkl) = (100) of the site 20 to 23 ° from the present, perovskite-dimensional structure of compound 2: case A 2 B (1-a) M a X (4 + δ) , the Usually it is a compound with a peak derived from (hkl)=(002) at the position of 2 θ=1 to 10°, preferably a compound derived from (hkl)=(002) exists at a position of 2 θ=2 to 8° The peak compound.

≪第2實施形態≫ ≪Second Embodiment≫

本實施形態之化合物具有下述通式(1)所示之鈣鈦礦結構,其中,A係1價陽離子,M係2價或3價金屬離子且係選自在6配位之離子半徑為0.9Å以上1.5Å以下之金屬離子之陽離子,X係選自由氯化物離子、溴化物離子、氟化物離子、碘化物離子及硫氰酸根離子所成之群組之1種以上之離子(惟,X至少含有氯化物離子或溴化物離子)。 The compound of this embodiment has a perovskite structure represented by the following general formula (1), in which A is a monovalent cation, M is a divalent or trivalent metal ion, and the ionic radius selected from 6 coordination is 0.9 Cations of metal ions above Å and below 1.5Å, X is selected from more than one ion selected from the group consisting of chloride ion, bromide ion, fluoride ion, iodide ion and thiocyanate ion (except, X Contain at least chloride ion or bromide ion).

APb(1-a)MaX(3+δ)(0<a≦0.7,0≦δ≦0.7)...(1) APb (1-a) M a X (3+δ) (0<a≦0.7, 0≦δ≦0.7). . . (1)

例如,當A為1價陽離子、B為2價陰離子(Pb離子)、M為2價或3價陰離子(金屬離子)、及X為1價陰離子(選自由氯化物離子、溴化物離子、氟化物離子、碘化物離子及硫氰酸根離子所成之群組之1種以上之離子)時,能以使前述化合物成為中性(電荷為0)之方式選擇δ。 For example, when A is a monovalent cation, B is a divalent anion (Pb ion), M is a divalent or trivalent anion (metal ion), and X is a monovalent anion (selected from chloride ion, bromide ion, fluorine ion) When the compound ion, iodide ion, and thiocyanate ion form one or more ions), δ can be selected so that the aforementioned compound becomes neutral (the charge is 0).

一般而言,鈣鈦礦結構之基本結構形態係A’B’X’3結構。 Generally speaking, the basic structure morphology of the perovskite structure is the A'B'X' 3 structure.

在此,本實施形態中,鈣鈦礦之基本結構形態係A’B’X’3結構且具有共用頂點之B’X’6八面體之3維網絡。A’B’X’3結構之B’成分可為採用X’陰離子之八面體配位之金屬陽離子。A’陽離子係位於以B’原子為中 心之六面體之各頂點,在本實施形態中為有機陽離子或無機陽離子。A’B’X’3結構之X’成分在本實施形態中通常係鹵化物離子。 Here, in this embodiment, the basic structural form of the perovskite is a three-dimensional network of A'B'X' 3 structure and a B'X' 6 octahedron with a common vertex. The B'component of the A'B'X' 3 structure can be a metal cation with an octahedral coordination of the X'anion. The A'cation is located at each vertex of the hexahedron centered on the B'atom, and is an organic cation or an inorganic cation in this embodiment. The X'component of the A'B'X' 3 structure is usually a halide ion in this embodiment.

本發明人等精心檢討之結果,發現具有上述鈣鈦礦結構之化合物之基本結構中,將B成分之金屬陽離子設為鉛,將複數個鉛離子之一部分以其他原子取代,藉此可提升前述化合物之發光強度。 As a result of careful review, the inventors found that in the basic structure of the compound with the above-mentioned perovskite structure, the metal cation of the B component is set to lead, and a part of the plural lead ions is replaced with other atoms, thereby improving the aforementioned The luminous intensity of the compound.

本實施形態中,具有通式(1)所示之鈣鈦礦結構之化合物(以下,有時記載為「化合物(1)」)係以A、Pb(鉛)、M及X為主成分。 In this embodiment, the compound having the perovskite structure represented by the general formula (1) (hereinafter, sometimes referred to as "compound (1)") has A, Pb (lead), M, and X as main components.

在此,M係意指將屬於金屬陽離子之Pb離子之一部分取代之原子。再者,前述基本結構中,M可取代B成分(鉛離子)存在之位置,亦可取代A成分存在之位置,亦可存在於構成前述基本結構之骨架之格子間隙。 Here, M means an atom that partially replaces a part of the Pb ion belonging to the metal cation. Furthermore, in the aforementioned basic structure, M may replace the position where the B component (lead ion) exists, or may replace the position where the A component exists, and may also exist in the lattice gaps constituting the skeleton of the aforementioned basic structure.

以下,說明本實施形態中之以A、B、X、及M為成分之具有鈣鈦礦型結晶結構之化合物。 Hereinafter, the compound having a perovskite-type crystal structure with A, B, X, and M as components in the present embodiment will be described.

[A] [A]

前述第1實施形態及前述第2實施形態之化合物中,A係1價陽離子。化合物中,A較佳係銫離子或有機銨離子。 In the compounds of the aforementioned first embodiment and the aforementioned second embodiment, A is a monovalent cation. Among the compounds, A is preferably cesium ion or organic ammonium ion.

就A之有機銨離子而言,具體上可列舉下述通式(A1)所示之陽離子。 As for the organic ammonium ion of A, specifically, the cation represented by the following general formula (A1) can be mentioned.

Figure 106105503-A0202-12-0009-1
Figure 106105503-A0202-12-0009-1

通式(A1)中,R1至R4分別獨立為氫原子或烷基,且構成各烷基之氫原子之1個可經胺基取代。 In the general formula (A1), R 1 to R 4 are each independently a hydrogen atom or an alkyl group, and one of the hydrogen atoms constituting each alkyl group may be substituted with an amino group.

就R1至R4之烷基而言,較佳係直鏈狀或分支鏈狀之烷基,更佳係碳數1至4之直鏈狀或分支鏈狀之烷基,再更佳係碳數1至3之直鏈狀或分支鏈狀之烷基。藉由使烷基之數量及烷基之碳數小,可得到具有發光特性之3維鈣鈦礦結構。又,R1至R4之烷基之碳數之合計數較佳係1至4,R1至R4中,特佳係R1為碳數1至3之烷基且R2至R4為氫原子。 Regarding the alkyl group of R 1 to R 4 , it is preferably a linear or branched alkyl group, more preferably a linear or branched alkyl group having 1 to 4 carbon atoms, and still more preferably A straight-chain or branched-chain alkyl group with 1 to 3 carbon atoms. By making the number of alkyl groups and the number of carbon atoms of the alkyl groups small, a three-dimensional perovskite structure with luminescent properties can be obtained. In addition, the total number of carbon atoms of the alkyl groups of R 1 to R 4 is preferably 1 to 4. Among R 1 to R 4 , it is particularly preferred that R 1 is an alkyl group of 1 to 3 carbons and R 2 to R 4 Is a hydrogen atom.

更具體而言,A較佳係CH3NH3 +、C2H5NH3 +或C3H7NH3 +,更佳係CH3NH3 +或C2H5NH3 +,最佳係CH3NH3 +(甲基銨離子)。 More specifically, A is preferably CH 3 NH 3 + , C 2 H 5 NH 3 + or C 3 H 7 NH 3 + , more preferably CH 3 NH 3 + or C 2 H 5 NH 3 + , most preferably It is CH 3 NH 3 + (methylammonium ion).

[B] [B]

本實施形態之具有鈣鈦礦結構之化合物中,B成分係成為結晶結構中心之金屬陽離子。本實施形態中,B成分係設為Pb(鉛)。本實施形態中之Pb離子係2價Pb離子。 In the compound having a perovskite structure of this embodiment, the B component is a metal cation that becomes the center of the crystal structure. In this embodiment, the B component is Pb (lead). The Pb ion in this embodiment is a divalent Pb ion.

本實施形態中,藉由將構成化合物之複數個結晶結構所含之B成分(Pb離子)之一部分以其他原子取代,可提升本實施形態之化合物之發光強度。 In this embodiment, by substituting a part of the B component (Pb ion) contained in a plurality of crystal structures of the constituent compound with other atoms, the luminous intensity of the compound of this embodiment can be increased.

[M] [M]

前述第1實施形態及前述第2實施形態之化合物中,M之至少一部分取代屬於金屬陽離子之Pb離子之一部分。 In the compounds of the aforementioned first embodiment and the aforementioned second embodiment, at least a part of M replaces a part of the Pb ion belonging to the metal cation.

更詳細而言,M係2價或3價金屬離子,且係選自在6配位之離子半徑為0.9Å以上1.5Å以下之金屬離子之陽離子。 In more detail, M is a divalent or trivalent metal ion, and is a cation selected from metal ions with an ionic radius of 0.9 Å or more and 1.5 Å or less in 6 coordination.

M所示之金屬離子之離子半徑較佳係0.95Å以上1.4Å以下,更佳係0.95Å以上1.3Å以下。 The ion radius of the metal ion indicated by M is preferably 0.95 Å or more and 1.4 Å or less, more preferably 0.95 Å or more and 1.3 Å or less.

從維持前述第1實施形態及前述第2實施形態之化合物之鈣鈦礦結晶結構並得到充分發光強度之觀點來看,就M而言,可列舉例如:鋇離子(在6配位之離子半徑:1.35Å)、鈣離子(在6配位之離子半徑:1.00Å)、鈰離子(在6配位之離子半徑:1.01Å)、鏑離子(在6配位之離子半徑:1.07Å)、鑭離子(在6配位之離子半徑:1.03Å)、釤離子(在6配位之離子半徑:1.19Å)、鍶離子(在6配位之離子半徑:1.18Å)、或鐿離子(在6配位之離子半徑:1.02Å)等元素之陽離子。其中,M較佳係鹼土金屬離子,更佳係鈣離子。 From the viewpoint of maintaining the perovskite crystal structure of the compounds of the first embodiment and the second embodiment and obtaining sufficient luminous intensity, as for M, for example, barium ions (the ionic radius coordinated at 6) :1.35Å), calcium ion (ionic radius coordinated at 6: 1.00Å), cerium ion (ionic radius coordinated at 6: 1.01Å), dysprosium ion (ionic radius coordinated at 6: 1.07Å), Lanthanum ion (ionic radius in 6 coordination: 1.03Å), samarium ion (ionic radius in 6 coordination: 1.19Å), strontium ion (ionic radius in 6 coordination: 1.18Å), or ytterbium ion (in 6 Coordinated ion radius: 1.02Å) and other element cations. Among them, M is preferably alkaline earth metal ion, more preferably calcium ion.

[a] [a]

從維持鈣鈦礦化合物之結晶結構並得到充分發光強度之觀點來看,前述M相對於Pb之取代量,當將a、M及Pb之莫耳比以a=M/(Pb+M)表示時,a係大於0且0.7以下。 a較佳係0.01以上0.7以下,更佳係0.02以上0.6以下。 From the viewpoint of maintaining the crystal structure of the perovskite compound and obtaining sufficient luminous intensity, the substitution amount of the aforementioned M with respect to Pb is expressed by the molar ratio of a, M and Pb as a=M/(Pb+M) When, a is greater than 0 and 0.7 or less. a is preferably not less than 0.01 and not more than 0.7, more preferably not less than 0.02 and not more than 0.6.

本實施形態中,a之值係下述{a之計算方法}所記載之從將合成後化合物使用ICP-MS測定之值計算出之值。 In this embodiment, the value of a is the value calculated from the value measured by ICP-MS of the compound after synthesis as described in the following {Calculation method of a}.

{a之計算方法} {a's calculation method}

本實施形態之化合物中,前述a,即前述莫耳比[M/(M+B)]之值可使用ICP-MS(ELAN DRCII,PerkinElmer製)而測定。前述莫耳比之測定係將具有鈣鈦礦型結晶結構之化合物使用硝酸等溶解後進行測定。 In the compound of this embodiment, the aforementioned a, that is, the value of the aforementioned molar ratio [M/(M+B)] can be measured using ICP-MS (ELAN DRCII, manufactured by PerkinElmer). The aforementioned measurement of the molar ratio is performed by dissolving a compound having a perovskite-type crystal structure using nitric acid or the like.

具體而言,莫耳比[M/(M+B)]之值係依據下述式(T)而計算出之值。下述式(T)中,Mmol係表示以ICP-MS所測定之M之莫耳數,Pbmol係表示以ICP-MS所測定之Pb之莫耳數。 Specifically, the value of the molar ratio [M/(M+B)] is a value calculated based on the following formula (T). In the following formula (T), Mmol represents the molar number of M measured by ICP-MS, and Pbmol represents the molar number of Pb measured by ICP-MS.

[M/(M+B)]=(Mmol)/(Mmol+Pbmol)...(T) [M/(M+B)]=(Mmol)/(Mmol+Pbmol). . . (T)

本實施形態中,從可更正確地計算出合成後化合物中之M相對於Pb之取代量之觀點來看,較佳係將藉由前述{a之計算方法}所計算出之值當作「a」。 In this embodiment, from the viewpoint that the substitution amount of M relative to Pb in the compound after synthesis can be calculated more accurately, it is preferable to use the value calculated by the aforementioned {a calculation method} as " a".

此外,簡化的方式來說,a之值亦可在合成本實施形態之化合物時,從使前述第1實施形態及前述第2實施形態之化合物中之a成為所期望之值之方式而經調整之饋入比之值計算出。 In addition, in a simplified way, the value of a can also be adjusted by adjusting the value of a in the compounds of the aforementioned first embodiment and the aforementioned second embodiment when synthesizing the compound of the present embodiment. The value of the feed-in ratio is calculated.

[X] [X]

X係選自由氯化物離子、溴化物離子、氟化物離子、碘化物離子及硫氰酸根離子所成之群組之1種以上之離子。惟,X至少含有氯化物離子或溴化物離子。 X is one or more ions selected from the group consisting of chloride ion, bromide ion, fluoride ion, iodide ion, and thiocyanate ion. However, X contains at least chloride ion or bromide ion.

X中,氯化物離子或溴化物離子之量,當以在X中之莫耳%表示時,較佳係10%以上,更佳係30%以上,再更佳係70%以上,特佳係80%以上。上限值無特別限定,只要為100%以下即可任意地選擇。 In X, the amount of chloride ion or bromide ion, when expressed in mole% in X, is preferably more than 10%, more preferably more than 30%, even more preferably more than 70%, especially preferred More than 80%. The upper limit is not particularly limited, and it can be arbitrarily selected as long as it is 100% or less.

其中,X較佳係含有溴化物離子。X為2種以上陰離子時,陰離子之含有比率可依發光波長而適當地選擇。 Among them, X preferably contains bromide ions. When X is two or more kinds of anions, the content ratio of the anions can be appropriately selected according to the emission wavelength.

選擇2種以上離子作為X時,較佳係溴化物離子與氯化物離子之組合、或溴化物離子與碘化物離子之組合。 When two or more kinds of ions are selected as X, it is preferably a combination of bromide ion and chloride ion, or a combination of bromide ion and iodide ion.

就前述第1實施形態及前述第2實施形態之化合物之具體例而言,可列舉CH3NH3Pb(1-a)CaaBr(3+δ)(0<a≦0.7,0≦δ≦0.7)、CH3NH3Pb(1-a)SraBr(3+δ)(0<a≦0.7,0≦δ≦0.7)、CH3NH3Pb(1-a)LaaBr(3+δ)(0<a≦0.7,0≦δ≦0.7)、CH3NH3Pb(1-a)BaaBr(3+δ)(0<a≦0.7,0≦δ≦0.7)、CH3NH3Pb(1-a)DyaBr(3+δ)(0<a≦0.7,0≦δ≦0.7)、CH3NH3Pb(1-a)Caa(Br2Cl)(3+δ)(0<a≦0.7,0≦δ≦0.7)、或CH3NH3Pb(1-a)Caa(Br2I)(3+δ)(0<a≦0.7,0≦δ≦0.7)等作為較佳者。 Specific examples of the compounds of the aforementioned first embodiment and the aforementioned second embodiment include CH 3 NH 3 Pb (1-a) Ca a Br (3+δ) (0<a≦0.7, 0≦δ) ≦0.7), CH 3 NH 3 Pb (1-a) Sr a Br (3+δ) (0<a≦0.7, 0≦δ≦0.7), CH 3 NH 3 Pb (1-a) La a Br ( 3+δ) (0<a≦0.7, 0≦δ≦0.7), CH 3 NH 3 Pb (1-a) Ba a Br (3+δ) (0<a≦0.7, 0≦δ≦0.7), CH 3 NH 3 Pb (1-a) Dy a Br (3+δ) (0<a≦0.7, 0≦δ≦0.7), CH 3 NH 3 Pb (1-a) Ca a (Br 2 Cl) ( 3+δ) (0<a≦0.7, 0≦δ≦0.7), or CH 3 NH 3 Pb (1-a) Ca a (Br 2 I) (3+δ) (0<a≦0.7, 0≦ δ≦0.7) and the like are preferable.

本實施形態之具有鈣鈦礦結構之化合物可藉由使用溶液之自我組織化反應而合成。 The compound with the perovskite structure of this embodiment can be synthesized by a self-organizing reaction using a solution.

例如,將使含有Pb及上述X之化合物、含有上述M 及上述X之化合物、含有上述A及上述X之化合物溶解於溶劑而成之溶液塗佈,將溶劑去除,藉此可合成本實施形態之具有鈣鈦礦結構之化合物。 For example, the compound containing Pb and the above X, and the compound containing the above M The compound of the above-mentioned X and the compound containing the above-mentioned A and the above-X are applied in a solvent and the solvent is removed, whereby the compound with the perovskite structure of this embodiment can be synthesized.

就其他方法而言,將使含有Pb及上述X之化合物、含有上述M及上述X之化合物溶解於溶劑而成之溶液塗佈,將溶劑去除,藉此形成塗佈膜。然後,將使含有上述A及上述X之化合物溶解於溶劑而成之溶液塗佈於上述塗佈膜上,將溶劑去除,藉此可合成本實施形態之具有鈣鈦礦結構之化合物。 In another method, a solution obtained by dissolving a compound containing Pb and the aforementioned X, and a compound containing the aforementioned M and the aforementioned X in a solvent is applied, and the solvent is removed to form a coating film. Then, a solution obtained by dissolving the compound containing the aforementioned A and the aforementioned X in a solvent is applied to the aforementioned coating film, and the solvent is removed, whereby the compound having a perovskite structure of this embodiment can be synthesized.

合成時,以使前述第1實施形態及前述第2實施形態之化合物中之a與δ成為所期望之值之方式調整上述調配之化合物之種類及其量即可。 At the time of synthesis, the type and amount of the compound to be formulated may be adjusted so that a and δ in the compound of the first embodiment and the second embodiment become desired values.

≪發光光譜≫ ≪Luminescence spectrum≫

本實施形態之具有鈣鈦礦結構之化合物係在可見光波長區域發出螢光之發光體,X為溴化物離子時,通常係發出480nm以上、較佳係500nm以上、更佳係520nm以上之波長範圍之螢光者。又,通常係發出700nm以下、較佳係600nm以下、更佳係580nm以下之波長範圍之螢光者。 The compound with the perovskite structure of this embodiment is a luminous body that emits fluorescence in the visible wavelength region. When X is bromide ion, it usually emits a wavelength range of 480 nm or more, preferably 500 nm or more, and more preferably 520 nm or more. The Fluorescent. In addition, it is usually a phosphor that emits a wavelength range of 700 nm or less, preferably 600 nm or less, and more preferably 580 nm or less.

上述之上限值及下限值可任意地組合。 The above upper limit and lower limit can be combined arbitrarily.

本實施形態之具有鈣鈦礦結構之化合物之最大發光強度可由使用螢光光度計所測定之可見光波長區域之最大強度、與使用紫外線可見光吸光光度計所測定之激發光之穿透率而求得。 The maximum luminous intensity of the compound with the perovskite structure of this embodiment can be obtained from the maximum intensity in the visible wavelength region measured by a fluorometer and the transmittance of excitation light measured by an ultraviolet-visible light absorbance photometer. .

就螢光光度計而言,可使用例如日本分光製之螢光光度計(FT-6500)。就紫外線可見光吸光光度計而言,可使用例如日本分光製之紫外線可見光吸光光度計(商品名:V-670)。 As for the fluorometer, for example, a fluorometer (FT-6500) manufactured by Japan Separation Co., Ltd. can be used. As for the ultraviolet-visible light absorbance photometer, for example, an ultraviolet-visible light absorbance photometer (trade name: V-670) manufactured by JASCO Corporation can be used.

本實施形態中,前述化合物之最大發光強度係依據下述式(S)而校正之值。下述式(S)中,Pmax係表示可見光波長區域之最大強度,Ep係表示激發光之穿透率(%)。 In this embodiment, the maximum luminous intensity of the aforementioned compound is a value corrected according to the following formula (S). In the following formula (S), Pmax represents the maximum intensity in the visible light wavelength region, and Ep represents the transmittance (%) of excitation light.

Pmax/(100-Ep)×100...(S) Pmax/(100-Ep)×100. . . (S)

<發光材料> <Luminescent Material>

本實施形態係提供含有前述第1實施形態及前述第2實施形態之化合物之發光材料。 This embodiment provides a luminescent material containing the compound of the aforementioned first embodiment and the aforementioned second embodiment.

使用前述第1實施形態及前述第2實施形態之化合物之發光材料亦可具有除了前述第1實施形態及前述第2實施形態之化合物以外之成分。例如,若干不純物、不具有鈣鈦礦結構之化合物,且亦可更含有具有與上述之前述第1實施形態及前述第2實施形態之化合物同樣或類似之組成之化合物。 The luminescent material using the compounds of the aforementioned first embodiment and the aforementioned second embodiment may have components other than the aforementioned compounds of the aforementioned first embodiment and the aforementioned second embodiment. For example, some impurities and compounds that do not have a perovskite structure, and may further contain compounds having the same or similar composition as the compounds of the aforementioned first embodiment and the aforementioned second embodiment.

含有具有鈣鈦礦結構之化合物之發光材料之形態無特別限定,可因應用途而適當地決定。可為將前述第1實施形態及前述第2實施形態之化合物做成膜狀之被膜,亦可為做成粉末狀並吸附於基材而成之吸附體。 The form of the luminescent material containing a compound having a perovskite structure is not particularly limited, and can be appropriately determined depending on the application. The compound of the aforementioned first embodiment and the aforementioned second embodiment may be a film-like coating, or it may be an adsorbent made of a powder and adsorbed to a substrate.

本實施形態之具有鈣鈦礦結構之化合物之被膜或吸附體,可將前述第1實施形態及前述第2實施形 態之化合物溶解於有機溶劑後,藉由凹版塗佈法、棒塗佈法、印刷法、噴霧法、旋轉塗佈法、浸漬法、或模具塗佈法等塗佈方法而形成。 The film or adsorbent of the compound having the perovskite structure of this embodiment can be combined with the first embodiment and the second embodiment described above. After the compound in the state is dissolved in an organic solvent, it is formed by a coating method such as a gravure coating method, a bar coating method, a printing method, a spray method, a spin coating method, a dipping method, or a die coating method.

有機溶劑只要是可將上述之A、Pb、M、X、及其他溶解前成分溶解成離子者即無特別限定。有機溶劑係各種有機化合物及可具有分支結構或環狀結構,可具有複數個-O-、-CO-、-COO-、或-OH等官能基,氫原子可經氟等鹵原子取代。就有機溶劑而言,可列舉例如:甲酸甲酯、甲酸乙酯、甲酸丙酯、甲酸戊酯、乙酸甲酯、乙酸乙酯、或乙酸戊酯等酯類;γ-丁內酯、N-甲基-2-吡咯啶酮、丙酮、二甲基酮、二異丁基酮、環戊酮、環己酮、或甲基環己酮等酮類;二乙基醚、甲基第三丁基醚、二異丙基醚、二甲氧基甲烷、二甲氧基乙烷、1,4-二

Figure 106105503-A0202-12-0015-9
烷、1,3-二氧雜環戊烷、4-甲基二氧雜環戊烷、四氫呋喃、甲基四氫呋喃、苯甲醚、或苯乙醚等醚類;甲醇、乙醇、1-丙醇、2-丙醇、1-丁醇、2-丁醇、第三丁醇、1-戊醇、2-甲基-2-丁醇、甲氧基丙醇、二丙酮醇、環己醇、2-氟乙醇、2,2,2-三氟乙醇、或2,2,3,3-四氟-1-丙醇等醇類;乙二醇單甲基醚、乙二醇單乙基醚、乙二醇單丁基醚、乙二醇單乙基醚乙酸酯、或三乙二醇二甲基醚等二醇醚類;N,N-二甲基甲醯胺、乙醯胺、或N,N-二甲基乙醯胺等醯胺系有機溶劑;乙腈、異丁腈、丙腈、或甲氧基乙腈等腈系有機溶劑;碳酸伸乙酯、或碳酸伸丙酯等碳酸酯系有機溶劑;氯化亞甲基、二氯甲烷、或氯仿等鹵化烴系有機溶劑;正戊烷、環己烷、正己 烷、苯、甲苯、或二甲苯等烴系有機溶劑;或二甲基亞碸等。 The organic solvent is not particularly limited as long as it can dissolve the aforementioned A, Pb, M, X, and other components before dissolution into ions. The organic solvent is a variety of organic compounds and may have a branched structure or a cyclic structure, and may have a plurality of functional groups such as -O-, -CO-, -COO-, or -OH, and hydrogen atoms may be substituted by halogen atoms such as fluorine. As for organic solvents, for example, esters such as methyl formate, ethyl formate, propyl formate, pentyl formate, methyl acetate, ethyl acetate, or pentyl acetate; γ-butyrolactone, N- Methyl-2-pyrrolidone, acetone, dimethyl ketone, diisobutyl ketone, cyclopentanone, cyclohexanone, or methyl cyclohexanone and other ketones; diethyl ether, methyl tertiary butyl Base ether, diisopropyl ether, dimethoxymethane, dimethoxyethane, 1,4-di
Figure 106105503-A0202-12-0015-9
Ethers such as alkane, 1,3-dioxolane, 4-methyldioxolane, tetrahydrofuran, methyltetrahydrofuran, anisole, or phenylethyl ether; methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, tertiary butanol, 1-pentanol, 2-methyl-2-butanol, methoxypropanol, diacetone alcohol, cyclohexanol, 2 -Alcohols such as fluoroethanol, 2,2,2-trifluoroethanol, or 2,2,3,3-tetrafluoro-1-propanol; ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, Glycol ethers such as ethylene glycol monobutyl ether, ethylene glycol monoethyl ether acetate, or triethylene glycol dimethyl ether; N,N-dimethylformamide, acetamide, or Amine-based organic solvents such as N,N-dimethylacetamide; Nitrile-based organic solvents such as acetonitrile, isobutyronitrile, propionitrile, or methoxyacetonitrile; carbonates such as ethylene carbonate or propylene carbonate Organic solvents; halogenated hydrocarbon-based organic solvents such as chlorinated methylene, dichloromethane, or chloroform; hydrocarbon-based organic solvents such as n-pentane, cyclohexane, n-hexane, benzene, toluene, or xylene; or dimethyl Keaqi et al.

又,較佳係將使前述第1實施形態及前述第2實施形態之化合物溶解於上述有機溶劑而成之溶液塗佈後,視需要而進行減壓、乾燥及送風之任一種以上,使有機溶劑揮發。乾燥可在常溫下進行,亦可加熱進行。加熱時之溫度可考量乾燥所需時間與基板耐熱性而適當地決定,較佳係50至200℃,更佳係50至100℃。 Furthermore, it is preferable to apply a solution obtained by dissolving the compound of the aforementioned first embodiment and the aforementioned second embodiment in the aforementioned organic solvent, and then performing any one or more of decompression, drying and air blowing as necessary to make the organic The solvent evaporates. Drying can be carried out at room temperature or heating. The temperature during heating can be appropriately determined in consideration of the time required for drying and the heat resistance of the substrate, and is preferably 50 to 200°C, more preferably 50 to 100°C.

此外,本實施形態之技術範圍不限於上述實施形態,可在不超出本實施形態之主旨之範圍內施加各種變更。 In addition, the technical scope of this embodiment is not limited to the above-mentioned embodiment, and various changes can be added within the range which does not deviate from the summary of this embodiment.

(實施例) (Example)

以下,依據實施例及比較例更具體地說明本發明之實施態樣,但本發明不限於以下實施例。 Hereinafter, the implementation aspects of the present invention will be described in more detail based on examples and comparative examples, but the present invention is not limited to the following examples.

(具有鈣鈦礦結構之化合物之合成) (Synthesis of compounds with perovskite structure) [實施例1] [Example 1]

準備2.5cm×2.5cm尺寸之玻璃基板。將該玻璃基板經臭氧UV處理。 Prepare a 2.5cm×2.5cm size glass substrate. The glass substrate was subjected to ozone UV treatment.

於70℃將溴化鉛(PbBr2)溶解於N,N-二甲基甲醯胺(以下,記載為「DMF」)溶劑而製作0.1M濃度之溴化鉛溶液。同樣地,於70℃將溴化鈣(CaBr2)溶解於DMF溶劑而製作0.1M濃度之溴化鈣溶液。繼而,於70℃將溴化甲基銨(CH3NH3Br)溶解於DMF溶劑而製作0.1M濃度之溴化甲基 銨溶液。 Lead bromide (PbBr 2 ) was dissolved in N,N-dimethylformamide (hereinafter referred to as "DMF") solvent at 70°C to prepare a lead bromide solution with a concentration of 0.1M. Similarly, calcium bromide (CaBr 2 ) was dissolved in a DMF solvent at 70°C to prepare a 0.1M calcium bromide solution. Then, methyl ammonium bromide (CH 3 NH 3 Br) was dissolved in a DMF solvent at 70° C. to prepare a 0.1 M methyl ammonium bromide solution.

將上述溴化鉛溶液與溴化鈣溶液,以莫耳比計算,以使Ca/(Ca+Pb)成為0.03之方式混合並製作溶液。將所得之混合溶液、與上述溴化甲基銨溶液,以莫耳比計算,以使溴化甲基銨/(Ca+Pb)=1之方式進一步混合溶液。 The above-mentioned lead bromide solution and calcium bromide solution were mixed in molar ratio so that Ca/(Ca+Pb) became 0.03 to prepare a solution. The obtained mixed solution and the above-mentioned methylammonium bromide solution are further mixed in molar ratio so that methylammonium bromide/(Ca+Pb)=1.

以1000rpm之旋轉數將前述溶液藉由旋轉塗佈而塗佈於上述玻璃基板,在大氣中於100℃乾燥10分鐘,而得到具有鈣鈦礦結構之化合物之塗佈膜。 The solution was applied to the glass substrate by spin coating at a rotation speed of 1000 rpm, and dried in the atmosphere at 100° C. for 10 minutes to obtain a coating film of a compound having a perovskite structure.

將前述塗佈膜之化合物以X射線繞射(XRD,Cu K α線,X’pert PRO MPD,Spectris公司製)之手段來測定,由此確認在2 θ=14°之位置具有源自(hkl)=(001)之峰值且為3維之鈣鈦礦結構。 The compound of the aforementioned coating film was measured by means of X-ray diffraction (XRD, Cu K α line, X'pert PRO MPD, manufactured by Spectris), and it was confirmed that the compound at 2 θ=14° has a source ( hkl) = the peak of (001) and is a 3-dimensional perovskite structure.

[實施例2] [Example 2]

除了將Ca/(Ca+Pb)設為0.05以外,以與上述實施例1同樣之方法得到具有鈣鈦礦結構之化合物之塗佈膜。 Except that Ca/(Ca+Pb) was set to 0.05, a coating film of a compound having a perovskite structure was obtained in the same manner as in Example 1 above.

[實施例3] [Example 3]

除了將Ca/(Ca+Pb)設為0.1以外,以與上述實施例1同樣之方法得到具有鈣鈦礦結構之化合物之塗佈膜。 Except that Ca/(Ca+Pb) was set to 0.1, a coating film of a compound having a perovskite structure was obtained in the same manner as in Example 1 above.

[實施例4] [Example 4]

除了將Ca/(Ca+Pb)設為0.2以外,以與上述實施例1同樣之方法得到具有鈣鈦礦結構之化合物之塗佈膜。 Except that Ca/(Ca+Pb) was set to 0.2, a coating film of a compound having a perovskite structure was obtained in the same manner as in Example 1 above.

[比較例1] [Comparative Example 1]

準備2.5cm×2.5cm尺寸之玻璃基板。將該玻璃基板經臭氧UV處理。 Prepare a 2.5cm×2.5cm size glass substrate. The glass substrate was subjected to ozone UV treatment.

於70℃將溴化鉛(PbBr2)溶解於DMF溶劑而製作0.1M濃度之溴化鉛溶液。於70℃將溴化甲基銨(CH3NH3Br)溶解於DMF溶劑而製作0.1M濃度之溴化甲基銨溶液。繼而,以莫耳比計算,以使溴化甲基銨/Pb=1之方式混合溶液。 Lead bromide (PbBr 2 ) was dissolved in DMF solvent at 70°C to prepare a lead bromide solution with a concentration of 0.1M. Methyl ammonium bromide (CH 3 NH 3 Br) was dissolved in DMF solvent at 70° C. to prepare a 0.1 M methyl ammonium bromide solution. Then, in terms of molar ratio, the solution was mixed so that methylammonium bromide/Pb=1.

以1000rpm之旋轉數將前述溶液藉由旋轉塗佈而塗佈於上述玻璃基板,於100℃乾燥10分鐘,而得到具有鈣鈦礦結構之化合物之塗佈膜。 The solution was applied to the glass substrate by spin coating at a rotation speed of 1000 rpm, and dried at 100° C. for 10 minutes to obtain a coating film of a compound having a perovskite structure.

[比較例2] [Comparative Example 2]

準備2.5cm×2.5cm尺寸之玻璃基板。將該玻璃基板經臭氧UV處理。 Prepare a 2.5cm×2.5cm size glass substrate. The glass substrate was subjected to ozone UV treatment.

於70℃將碘化鉛(PbI2)溶解於DMF溶劑而製作0.1M濃度之碘化鉛溶液。於70℃將碘化甲基銨(CH3NH3I)溶解於DMF溶劑而製作0.1M濃度之碘化甲基銨溶液。繼而,以莫耳比計算,以使碘化甲基銨/Pb=1之方式混合溶液。 Lead iodide (PbI 2 ) was dissolved in DMF solvent at 70°C to prepare a lead iodide solution with a concentration of 0.1M. Methyl ammonium iodide (CH 3 NH 3 I) was dissolved in DMF solvent at 70° C. to prepare a 0.1 M concentration of methyl ammonium iodide solution. Then, in terms of molar ratio, the solution was mixed so that methylammonium iodide/Pb=1.

以1000rpm之旋轉數將前述溶液藉由旋轉塗佈而塗佈於上述玻璃基板,於100℃乾燥10分鐘,而得到具有鈣鈦礦結構之化合物之塗佈膜。 The solution was applied to the glass substrate by spin coating at a rotation speed of 1000 rpm, and dried at 100° C. for 10 minutes to obtain a coating film of a compound having a perovskite structure.

[比較例3] [Comparative Example 3]

準備2.5cm×2.5cm尺寸之玻璃基板。將該玻璃基板經臭氧UV處理。 Prepare a 2.5cm×2.5cm size glass substrate. The glass substrate was subjected to ozone UV treatment.

於70℃將碘化鉛(PbI2)溶解於DMF溶劑而製作0.1M濃度之碘化鉛溶液。同樣地,於70℃將碘化鈣(CaI2)溶解於DMF溶劑而製作0.1M濃度之碘化鈣溶液。 Lead iodide (PbI 2 ) was dissolved in DMF solvent at 70°C to prepare a lead iodide solution with a concentration of 0.1M. Similarly, calcium iodide (CaI 2 ) was dissolved in DMF solvent at 70°C to prepare a calcium iodide solution with a concentration of 0.1M.

將上述碘化鉛溶液與碘化鈣溶液,以莫耳比計算,以使Ca/(Ca+Pb)成為0.05之方式混合並製作溶液。將所得之混合溶液、與[實施例1]所記載之溴化甲基銨溶液,以莫耳比計算,以使溴化甲基銨/(Ca+Pb)=1之方式進一步混合溶液。 The above-mentioned lead iodide solution and calcium iodide solution were mixed in molar ratio so that Ca/(Ca+Pb) became 0.05 to prepare a solution. The obtained mixed solution and the methylammonium bromide solution described in [Example 1] were further mixed in molar ratio so that methylammonium bromide/(Ca+Pb)=1.

以1000rpm之旋轉數將前述溶液藉由旋轉塗佈而塗佈於上述玻璃基板,在大氣中於100℃乾燥10分鐘,而得到具有鈣鈦礦結構之化合物之塗佈膜。 The solution was applied to the glass substrate by spin coating at a rotation speed of 1000 rpm, and dried in the atmosphere at 100° C. for 10 minutes to obtain a coating film of a compound having a perovskite structure.

(發光光譜測定) (Luminescence spectrum measurement)

使用螢光光度計(日本分光製,商品名FT-6500,430nm以下波長截止濾波器,激發光430nm,感度high)測定實施例1至4及比較例1所得之具有鈣鈦礦結構之化合物之塗佈膜之發光光譜。又,使用紫外線可見光吸光光度計測定前述塗佈膜之穿透率(%)。就紫外線可見光吸光光度計而言,使用日本分光製,商品名V-670(以下亦使用相同機器)。 Using a fluorometer (manufactured by JASCO Corporation, trade name FT-6500, wavelength cut-off filter below 430nm, excitation light 430nm, high sensitivity) was used to measure the perovskite structure compounds obtained in Examples 1 to 4 and Comparative Example 1 Luminescence spectrum of coated film. In addition, the transmittance (%) of the aforementioned coating film was measured using an ultraviolet-visible light absorbance photometer. As for the ultraviolet visible light absorbance photometer, the product name V-670 manufactured by JASCO Corporation (the same machine is also used below).

此外,前述塗佈膜間之發光強度之比較係將波長530nm附近之最大發光強度以下述式(S)-1校正並進行。 In addition, the comparison of the luminous intensity between the aforementioned coating films was performed by correcting the maximum luminous intensity near the wavelength of 530 nm by the following formula (S)-1.

[波長530nm附近之最大發光強度/(100-波長430nm之穿透 率)]×100...(S)-1 [Maximum luminous intensity near wavelength 530nm/(100-wavelength 430nm penetration Rate)]×100. . . (S)-1

(發光光譜測定) (Luminescence spectrum measurement)

使用螢光光度計(日本分光製、商品名FT-6500、600nm以下波長截止濾波器、激發光550nm、感度high)測定比較例2及3所得之具有鈣鈦礦結構之化合物之塗佈膜之發光光譜。又,使用紫外線可見光吸光光度計測定前述塗佈膜之穿透率。 The coating film of the compound with the perovskite structure obtained in Comparative Examples 2 and 3 was measured using a fluorometer (manufactured by JASCO Corporation, trade name FT-6500, wavelength cut-off filter below 600nm, excitation light 550nm, high sensitivity) Luminescence spectrum. In addition, the transmittance of the aforementioned coating film was measured using an ultraviolet-visible light absorbance photometer.

此外,前述塗佈膜間之發光強度之比較係將波長750nm附近之最大發光強度以下述式(S)-2校正並進行。 In addition, the comparison of the luminous intensity between the aforementioned coating films was performed by correcting the maximum luminous intensity near the wavelength of 750 nm with the following formula (S)-2.

[波長750nm附近之最大發光強度/(100-波長550nm之穿透率)]×100...(S)-2 [Maximum luminous intensity near wavelength 750nm/(100-transmittance at wavelength 550nm)]×100. . . (S)-2

於下述表1記載實施例1至4、比較例1至3之具有鈣鈦礦結構之化合物之溶液製作之構成、最大發光強度。表1中,「M/(M+Pb)」係上述通式(1)中之「a」之饋入比中之值。 In the following Table 1, the constitution and the maximum luminous intensity of the solutions of the compounds with the perovskite structure of Examples 1 to 4 and Comparative Examples 1 to 3 are described. In Table 1, "M/(M+Pb)" is the value in the feed ratio of "a" in the above general formula (1).

Figure 106105503-A0202-12-0020-2
Figure 106105503-A0202-12-0020-2

由上述結果,含有本實施形態之具有鈣鈦礦結構之化合物之實施例1至4之發光材料,與比較例1至3之具有鈣鈦礦結構之化合物相比,可確認具有優異發光強度。 From the above results, it can be confirmed that the luminescent materials of Examples 1 to 4 containing the perovskite structure compound of this embodiment have superior luminous intensity compared with the perovskite structure compound of Comparative Examples 1 to 3.

(具有鈣鈦礦結構之化合物之合成) (Synthesis of compounds with perovskite structure) [實施例5] [Example 5]

準備2.5cm×2.5cm尺寸之玻璃基板。將該玻璃基板經臭氧UV處理。 Prepare a 2.5cm×2.5cm size glass substrate. The glass substrate was subjected to ozone UV treatment.

於70℃將溴化鉛(PbBr2)溶解於DMF溶劑而製作0.1M濃度之溴化鉛溶液。同樣地,於70℃將溴化鍶(SrBr2)溶解於DMF溶劑而製作0.1M濃度之溴化鍶溶液。繼而,於70℃將溴化甲基銨(CH3NH3Br)溶解於DMF溶劑而製作0.1M濃度之溴化甲基銨溶液。 Lead bromide (PbBr 2 ) was dissolved in DMF solvent at 70°C to prepare a lead bromide solution with a concentration of 0.1M. Similarly, strontium bromide (SrBr 2 ) was dissolved in DMF solvent at 70° C. to prepare a 0.1 M concentration of strontium bromide solution. Then, methyl ammonium bromide (CH 3 NH 3 Br) was dissolved in a DMF solvent at 70° C. to prepare a 0.1 M methyl ammonium bromide solution.

將上述溴化鉛溶液與溴化鍶溶液,以莫耳比計算,以使Sr/(Sr+Pb)成為0.1之方式混合並製作溶液。將所得之混合溶液、與上述溴化甲基銨溶液,以莫耳比計算,以使溴化甲基銨/(Sr+Pb)=1之方式進一步混合溶液。 The above-mentioned lead bromide solution and strontium bromide solution were mixed in molar ratio so that Sr/(Sr+Pb) became 0.1 to prepare a solution. The obtained mixed solution and the above-mentioned methyl ammonium bromide solution are further mixed in a molar ratio such that methyl ammonium bromide/(Sr+Pb)=1.

以1000rpm之旋轉數將前述溶液藉由旋轉塗佈而塗佈於上述玻璃基板,在大氣中於100℃乾燥10分鐘,而得到具有鈣鈦礦結構之化合物之塗佈膜。 The solution was applied to the glass substrate by spin coating at a rotation speed of 1000 rpm, and dried in the atmosphere at 100° C. for 10 minutes to obtain a coating film of a compound having a perovskite structure.

[實施例6] [Example 6]

除了將Sr/(Sr+Pb)設為0.2以外,以與上述實施例5同 樣之方法得到具有鈣鈦礦結構之化合物之塗佈膜。 Except that Sr/(Sr+Pb) is set to 0.2, it is the same as the above embodiment 5 In this way, a coating film of a compound with a perovskite structure is obtained.

[實施例7] [Example 7]

除了將Sr/(Sr+Pb)設為0.3以外,以與上述實施例5同樣之方法得到具有鈣鈦礦結構之化合物之塗佈膜。 Except that Sr/(Sr+Pb) was set to 0.3, a coating film of a compound having a perovskite structure was obtained in the same manner as in Example 5 above.

[實施例8] [Example 8]

除了將Sr/(Sr+Pb)設為0.5以外,以與上述實施例5同樣之方法得到具有鈣鈦礦結構之化合物之塗佈膜。 Except that Sr/(Sr+Pb) was set to 0.5, a coating film of a compound having a perovskite structure was obtained in the same manner as in Example 5 above.

[實施例9] [Example 9]

準備2.5cm×2.5cm尺寸之玻璃基板。將該玻璃基板經臭氧UV處理。 Prepare a 2.5cm×2.5cm size glass substrate. The glass substrate was subjected to ozone UV treatment.

於70℃將溴化鉛(PbBr2)溶解於DMF溶劑而製作0.1M濃度之溴化鉛溶液。同樣地,於70℃將溴化鑭(LaBr3)溶解於DMF溶劑而製作0.1M濃度之溴化鑭溶液。繼而,於70℃將溴化甲基銨(CH3NH3Br)溶解於DMF溶劑而製作0.1M濃度之溴化甲基銨溶液。 Lead bromide (PbBr 2 ) was dissolved in DMF solvent at 70°C to prepare a lead bromide solution with a concentration of 0.1M. Similarly, lanthanum bromide (LaBr 3 ) was dissolved in DMF solvent at 70° C. to prepare a 0.1 M concentration of lanthanum bromide solution. Then, methyl ammonium bromide (CH 3 NH 3 Br) was dissolved in a DMF solvent at 70° C. to prepare a 0.1 M methyl ammonium bromide solution.

將上述溴化鉛溶液與溴化鑭溶液,以莫耳比計算,以使La/(La+Pb)成為0.05之方式混合並製作溶液。將所得之混合溶液、與上述溴化甲基銨溶液,以莫耳比計算,以使溴化甲基銨/(La+Pb)=1之方式進一步混合溶液。 The above-mentioned lead bromide solution and lanthanum bromide solution were mixed in molar ratio so that La/(La+Pb) became 0.05 to prepare a solution. The obtained mixed solution and the above-mentioned methyl ammonium bromide solution are further mixed in a molar ratio such that methyl ammonium bromide/(La+Pb)=1.

以1000rpm之旋轉數將前述溶液藉由旋轉塗佈而塗佈於上述玻璃基板,在大氣中於100℃乾燥10分鐘,而得到 具有鈣鈦礦結構之化合物之塗佈膜。 The solution was applied to the glass substrate by spin coating at a rotation speed of 1000 rpm, and dried in the atmosphere at 100°C for 10 minutes to obtain Coating film of compound with perovskite structure.

[實施例10] [Example 10]

除了將La/(La+Pb)設為0.1以外,以與實施例9同樣之方法得到具有鈣鈦礦結構之化合物之塗佈膜。 Except that La/(La+Pb) was set to 0.1, a coating film of a compound having a perovskite structure was obtained in the same manner as in Example 9.

(發光光譜測定) (Luminescence spectrum measurement)

發光強度之比較方法係以與上述實施例1至4及比較例1同樣之方法而進行。 The comparison method of the luminous intensity was performed in the same manner as in the above-mentioned Examples 1 to 4 and Comparative Example 1.

於下述表2記載實施例5至10及比較例1之具有鈣鈦礦結構之化合物之溶液製作之構成、最大發光強度。表2中,「M/(M+Pb)」係上述通式(1)中之「a」之饋入比中之值。 Table 2 below describes the structure and maximum luminous intensity prepared by the solution of the compound with the perovskite structure of Examples 5 to 10 and Comparative Example 1. In Table 2, "M/(M+Pb)" is the value of the feed-in ratio of "a" in the above general formula (1).

Figure 106105503-A0202-12-0023-3
Figure 106105503-A0202-12-0023-3

由上述結果,含有本實施形態之具有鈣鈦礦結構之化合物之實施例5至10之發光材料,與比較例1 之具有鈣鈦礦結構之化合物相比,可確認具有優異發光強度。 From the above results, the luminescent materials of Examples 5 to 10 containing the compound with the perovskite structure of this embodiment are compared with Comparative Example 1. Compared with the compound with perovskite structure, it can be confirmed that it has excellent luminous intensity.

≪藉由ICP-MS進行之測定≫ ≪Measurement by ICP-MS≫

對實施例5至8所得之在玻璃基板上之具有鈣鈦礦型結晶結構之化合物添加硝酸1mL,使具有鈣鈦礦型結晶結構之化合物溶解。將溶解後之溶液使用離子交換水而使合計為10ml,藉由ICP-MS(ELAN DRCII,PerkinElmer製)測定Pb及M之量,將具有鈣鈦礦型結晶結構之化合物所含之M量代入(M)/(M+Pb)之式中,進行評估。 1 mL of nitric acid was added to the compound having the perovskite crystal structure on the glass substrate obtained in Examples 5 to 8 to dissolve the compound having the perovskite crystal structure. Use ion-exchanged water to make a total of 10 ml of the dissolved solution, measure the amount of Pb and M by ICP-MS (ELAN DRCII, manufactured by PerkinElmer), and substitute the amount of M contained in the compound with a perovskite crystal structure In the formula of (M)/(M+Pb), evaluate.

藉由ICP-MS進行之測定之結果,實施例5之[M/(M+Pb)]之值為0.10。 As a result of the measurement performed by ICP-MS, the value of [M/(M+Pb)] in Example 5 is 0.10.

藉由ICP-MS進行之測定之結果,實施例6之[M/(M+Pb)]之值為0.20。 As a result of the measurement performed by ICP-MS, the value of [M/(M+Pb)] in Example 6 is 0.20.

藉由ICP-MS進行之測定之結果,實施例7之[M/(M+Pb)]之值為0.29。 As a result of the measurement by ICP-MS, the value of [M/(M+Pb)] in Example 7 is 0.29.

藉由ICP-MS進行之測定之結果,實施例8之[M/(M+Pb)]之值為0.51。 As a result of the measurement performed by ICP-MS, the value of [M/(M+Pb)] in Example 8 is 0.51.

[實施例11] [Example 11]

準備2.5cm×2.5cm尺寸之玻璃基板。將該玻璃基板經臭氧UV處理。 Prepare a 2.5cm×2.5cm size glass substrate. The glass substrate was subjected to ozone UV treatment.

於70℃將溴化鉛(PbBr2)溶解於N,N-二甲基甲醯胺(以下,記載為「DMF」)溶劑而製作0.1M濃度之溴化鉛溶液。 同樣地,於70℃將溴化鋇(BaBr2)溶解於DMF溶劑而製作0.1M濃度之溴化鋇溶液。繼而,於70℃將溴化甲基銨(CH3NH3Br)溶解於DMF溶劑而製作0.1M濃度之溴化甲基銨溶液。 Lead bromide (PbBr 2 ) was dissolved in N,N-dimethylformamide (hereinafter referred to as "DMF") solvent at 70°C to prepare a lead bromide solution with a concentration of 0.1M. Similarly, barium bromide (BaBr 2 ) was dissolved in DMF solvent at 70°C to prepare a barium bromide solution with a concentration of 0.1M. Then, methyl ammonium bromide (CH 3 NH 3 Br) was dissolved in a DMF solvent at 70° C. to prepare a 0.1 M methyl ammonium bromide solution.

將上述溴化鉛溶液與溴化鋇溶液,以莫耳比計算,以使Ba/(Ba+Pb)成為0.03之方式混合並製作溶液。將所得之混合溶液、與上述溴化甲基銨溶液,以莫耳比計算,以使溴化甲基銨/(Ba+Pb)=1之方式進一步混合溶液。 The above-mentioned lead bromide solution and barium bromide solution were mixed in molar ratio so that Ba/(Ba+Pb) became 0.03 to prepare a solution. The obtained mixed solution and the above-mentioned methyl ammonium bromide solution are further mixed in a molar ratio such that methyl ammonium bromide/(Ba+Pb)=1.

以1000rpm之旋轉數將前述溶液藉由旋轉塗佈而塗佈於上述玻璃基板,在大氣中於100℃乾燥10分鐘,而得到具有鈣鈦礦結構之化合物之塗佈膜。 The solution was applied to the glass substrate by spin coating at a rotation speed of 1000 rpm, and dried in the atmosphere at 100° C. for 10 minutes to obtain a coating film of a compound having a perovskite structure.

[實施例12] [Example 12]

除了將Ba/(Ba+Pb)設為0.05以外,以與上述實施例11同樣之方法得到具有鈣鈦礦結構之化合物之塗佈膜。 Except that Ba/(Ba+Pb) was set to 0.05, a coating film of a compound having a perovskite structure was obtained in the same manner as in Example 11 above.

[實施例13] [Example 13]

除了將Ba/(Ba+Pb)設為0.1以外,以與上述實施例11同樣之方法得到具有鈣鈦礦結構之化合物之塗佈膜。 Except that Ba/(Ba+Pb) was set to 0.1, a coating film of a compound having a perovskite structure was obtained in the same manner as in Example 11 above.

[實施例14] [Example 14]

準備2.5cm×2.5cm尺寸之玻璃基板。將該玻璃基板經臭氧UV處理。 Prepare a 2.5cm×2.5cm size glass substrate. The glass substrate was subjected to ozone UV treatment.

於70℃將溴化鉛(PbBr2)溶解於N,N-二甲基甲醯胺(以 下,記載為「DMF」)溶劑而製作0.1M濃度之溴化鉛溶液。同樣地,於70℃將溴化鏑(DyBr3)溶解於DMF溶劑而製作0.1M濃度之溴化鏑溶液。繼而,於70℃將溴化甲基銨(CH3NH3Br)溶解於DMF溶劑而製作0.1M濃度之溴化甲基銨溶液。 Lead bromide (PbBr 2 ) was dissolved in N,N-dimethylformamide (hereinafter referred to as "DMF") solvent at 70°C to prepare a lead bromide solution with a concentration of 0.1M. Similarly, dysprosium bromide (DyBr 3 ) was dissolved in a DMF solvent at 70°C to prepare a 0.1M dysprosium bromide solution. Then, methyl ammonium bromide (CH 3 NH 3 Br) was dissolved in a DMF solvent at 70° C. to prepare a 0.1 M methyl ammonium bromide solution.

將上述溴化鉛溶液與溴化鏑溶液,以莫耳比計算,以使Dy/(Dy+Pb)成為0.1之方式混合並製作溶液。將所得之混合溶液、與上述溴化甲基銨溶液,以莫耳比計算,以使溴化甲基銨/(Dy+Pb)=1之方式進一步混合溶液。 The above-mentioned lead bromide solution and dysprosium bromide solution are mixed in molar ratio so that Dy/(Dy+Pb) becomes 0.1 to prepare a solution. The obtained mixed solution and the above-mentioned methyl ammonium bromide solution are further mixed in a molar ratio such that methyl ammonium bromide/(Dy+Pb)=1.

以1000rpm之旋轉數將前述溶液藉由旋轉塗佈而塗佈於上述玻璃基板,在大氣中於100℃乾燥10分鐘,而得到具有鈣鈦礦結構之化合物之塗佈膜。 The solution was applied to the glass substrate by spin coating at a rotation speed of 1000 rpm, and dried in the atmosphere at 100° C. for 10 minutes to obtain a coating film of a compound having a perovskite structure.

[實施例15] [Example 15]

準備2.5cm×2.5cm尺寸之玻璃基板。將該玻璃基板經臭氧UV處理。 Prepare a 2.5cm×2.5cm size glass substrate. The glass substrate was subjected to ozone UV treatment.

70℃將溴化鉛(PbBr2)溶解於N,N-二甲基甲醯胺(以下,記載為「DMF」)溶劑而製作0.1M濃度之溴化鉛溶液。同樣地,於70℃將溴化鈣(CaBr2)溶解於DMF溶劑而製作0.1M濃度之溴化鈣溶液。繼而,於70℃將氯化甲基銨(CH3NH3Cl)溶解於DMF溶劑而製作0.1M濃度之氯化甲基銨溶液。 Lead bromide (PbBr 2 ) was dissolved in N,N-dimethylformamide (hereinafter, referred to as "DMF") solvent at 70°C to prepare a lead bromide solution with a concentration of 0.1M. Similarly, calcium bromide (CaBr 2 ) was dissolved in a DMF solvent at 70°C to prepare a 0.1M calcium bromide solution. Then, methyl ammonium chloride (CH 3 NH 3 Cl) was dissolved in a DMF solvent at 70° C. to prepare a 0.1 M concentration of methyl ammonium chloride solution.

將上述溴化鉛溶液與溴化鈣溶液,以莫耳比計算,以使Ca/(Ca+Pb)成為0.1之方式混合製作並溶液。將所得之 混合溶液、與上述氯化甲基銨溶液,以莫耳比計算,以使氯化甲基銨/(Ca+Pb)=1之方式進一步混合溶液。 The above-mentioned lead bromide solution and calcium bromide solution were mixed so that Ca/(Ca+Pb) became 0.1 in molar ratio to prepare a solution. Will get The mixed solution and the above-mentioned methyl ammonium chloride solution are further mixed in a molar ratio such that methyl ammonium chloride/(Ca+Pb)=1.

以1000rpm之旋轉數將前述溶液藉由旋轉塗佈而塗佈於上述玻璃基板,在大氣中於100℃乾燥10分鐘,而得到具有鈣鈦礦結構之化合物之塗佈膜。 The solution was applied to the glass substrate by spin coating at a rotation speed of 1000 rpm, and dried in the atmosphere at 100° C. for 10 minutes to obtain a coating film of a compound having a perovskite structure.

[實施例16] [Example 16]

準備2.5cm×2.5cm尺寸之玻璃基板。將該玻璃基板經臭氧UV處理。 Prepare a 2.5cm×2.5cm size glass substrate. The glass substrate was subjected to ozone UV treatment.

於70℃將溴化鉛(PbBr2)溶解於N,N-二甲基甲醯胺(以下,記載為「DMF」)溶劑而製作0.1M濃度之溴化鉛溶液。同樣地,於70℃將溴化鈣(CaBr2)溶解於DMF溶劑而製作0.1M濃度之溴化鈣溶液。繼而,於70℃將碘化甲基銨(CH3NH3I)溶解於DMF溶劑而製作0.1M濃度之碘化甲基銨溶液。 Lead bromide (PbBr 2 ) was dissolved in N,N-dimethylformamide (hereinafter referred to as "DMF") solvent at 70°C to prepare a lead bromide solution with a concentration of 0.1M. Similarly, calcium bromide (CaBr 2 ) was dissolved in a DMF solvent at 70°C to prepare a 0.1M calcium bromide solution. Next, methyl ammonium iodide (CH 3 NH 3 I) was dissolved in a DMF solvent at 70° C. to prepare a 0.1 M methyl ammonium iodide solution.

將上述溴化鉛溶液與溴化鈣溶液,以莫耳比計算,以使Ca/(Ca+Pb)成為0.1之方式混合並製作溶液。將所得之混合溶液、與上述碘化甲基銨溶液,以莫耳比計算,以使碘化甲基銨/(Ca+Pb)=1之方式進一步混合溶液。 The above-mentioned lead bromide solution and calcium bromide solution are mixed in molar ratio so that Ca/(Ca+Pb) becomes 0.1 to prepare a solution. The obtained mixed solution and the above-mentioned methyl ammonium iodide solution are further mixed in a molar ratio such that methyl ammonium iodide/(Ca+Pb)=1.

以1000rpm之旋轉數將前述溶液藉由旋轉塗佈而塗佈於上述玻璃基板,在大氣中於100℃乾燥10分鐘,而得到具有鈣鈦礦結構之化合物之塗佈膜。 The solution was applied to the glass substrate by spin coating at a rotation speed of 1000 rpm, and dried in the atmosphere at 100° C. for 10 minutes to obtain a coating film of a compound having a perovskite structure.

[比較例4] [Comparative Example 4]

準備2.5cm×2.5cm尺寸之玻璃基板。將該玻璃基板經臭氧UV處理。 Prepare a 2.5cm×2.5cm size glass substrate. The glass substrate was subjected to ozone UV treatment.

於70℃將溴化鉛(PbBr2)溶解於N,N-二甲基甲醯胺(以下,記載為「DMF」)溶劑而製作0.1M濃度之溴化鉛溶液。繼而,於70℃將氯化甲基銨(CH3NH3Cl)溶解於DMF溶劑而製作0.1M濃度之氯化甲基銨溶液。繼而,以莫耳比計算,以使氯化甲基銨/(Pb)=1之方式進一步混合溶液。 Lead bromide (PbBr 2 ) was dissolved in N,N-dimethylformamide (hereinafter referred to as "DMF") solvent at 70°C to prepare a lead bromide solution with a concentration of 0.1M. Then, methyl ammonium chloride (CH 3 NH 3 Cl) was dissolved in a DMF solvent at 70° C. to prepare a 0.1 M concentration of methyl ammonium chloride solution. Then, in terms of molar ratio, the solution was further mixed so that methylammonium chloride/(Pb)=1.

以1000rpm之旋轉數將前述溶液藉由旋轉塗佈而塗佈於上述玻璃基板,在大氣中於100℃乾燥10分鐘而得到具有鈣鈦礦結構之化合物之塗佈膜。 The solution was applied to the glass substrate by spin coating at a rotation speed of 1000 rpm, and dried in the atmosphere at 100° C. for 10 minutes to obtain a coating film of a compound having a perovskite structure.

[比較例5] [Comparative Example 5]

準備2.5cm×2.5cm尺寸之玻璃基板。將該玻璃基板經臭氧UV處理。 Prepare a 2.5cm×2.5cm size glass substrate. The glass substrate was subjected to ozone UV treatment.

於70℃將溴化鉛(PbBr2)溶解於N,N-二甲基甲醯胺(以下,記載為「DMF」)溶劑而製作0.1M濃度之溴化鉛溶液。繼而,於70℃將碘化甲基銨(CH3NH3I)溶解於DMF溶劑而製作0.1M濃度之碘化甲基銨溶液。繼而,以莫耳比計算,以使碘化甲基銨/(Pb)=1之方式進一步混合溶液。 Lead bromide (PbBr 2 ) was dissolved in N,N-dimethylformamide (hereinafter referred to as "DMF") solvent at 70°C to prepare a lead bromide solution with a concentration of 0.1M. Next, methyl ammonium iodide (CH 3 NH 3 I) was dissolved in a DMF solvent at 70° C. to prepare a 0.1 M methyl ammonium iodide solution. Then, in terms of molar ratio, the solution was further mixed so that methylammonium iodide/(Pb)=1.

以1000rpm之旋轉數將前述溶液藉由旋轉塗佈而塗佈於上述玻璃基板,在大氣中於100℃乾燥10分鐘,而得到具有鈣鈦礦結構之化合物之塗佈膜。 The solution was applied to the glass substrate by spin coating at a rotation speed of 1000 rpm, and dried in the atmosphere at 100° C. for 10 minutes to obtain a coating film of a compound having a perovskite structure.

(發光光譜測定) (Luminescence spectrum measurement)

使用螢光光度計(日本分光製,商品名FT-6500,激發光430nm,感度High)測定實施例11至14所得之具有鈣鈦礦結構之化合物之塗佈膜之發光光譜。又,使用紫外線可見光吸光光度計測定前述塗佈膜之穿透率(%)。 The luminescence spectrum of the coating film of the compound having the perovskite structure obtained in Examples 11 to 14 was measured using a fluorometer (manufactured by JASCO Corporation, trade name FT-6500, excitation light 430 nm, high sensitivity). In addition, the transmittance (%) of the aforementioned coating film was measured using an ultraviolet-visible light absorbance photometer.

此外,前述塗佈膜間之發光強度之比較係將波長530nm附近之最大發光強度以下述式(S)-3校正並進行。 In addition, the comparison of the luminous intensity between the aforementioned coating films was performed by correcting the maximum luminous intensity around the wavelength of 530 nm with the following formula (S)-3.

[波長530nm附近之最大發光強度/(100-波長430nm之穿透率)]×100...(S)-3 [Maximum luminous intensity near wavelength 530nm/(100-transmittance at wavelength 430nm)]×100. . . (S)-3

(發光光譜測定) (Luminescence spectrum measurement)

使用螢光光度計(日本分光製,商品名FT-6500,激發光430nm,感度High)測定實施例15及比較例4所得之具有鈣鈦礦結構之化合物之塗佈膜之發光光譜。又,使用紫外線可見光吸光光度計測定前述塗佈膜之穿透率(%)。 The luminescence spectrum of the coating film of the compound having the perovskite structure obtained in Example 15 and Comparative Example 4 was measured using a fluorometer (manufactured by JASCO Corporation, trade name FT-6500, excitation light 430 nm, high sensitivity). In addition, the transmittance (%) of the aforementioned coating film was measured using an ultraviolet-visible light absorbance photometer.

此外,前述塗佈膜間之發光強度之比較係將波長500nm附近之最大發光強度以下述式(S)-4校正並進行。 In addition, the comparison of the luminous intensity between the aforementioned coating films was performed by correcting the maximum luminous intensity near the wavelength of 500 nm by the following formula (S)-4.

[波長500nm附近之最大發光強度/(100-波長430nm之穿透率)]×100...(S)-4 [Maximum luminous intensity near wavelength 500nm/(100-transmittance at wavelength 430nm)]×100. . . (S)-4

(發光光譜測定) (Luminescence spectrum measurement)

使用螢光光度計(日本分光製,商品名FT-6500,激發光430nm,感度High)測定實施例16及比較例5所得之具有鈣鈦礦結構之化合物之塗佈膜之發光光譜。又,使用紫外線可見光吸光光度計測定前述塗佈膜之穿透率(%)。 The luminescence spectrum of the coating film of the compound having the perovskite structure obtained in Example 16 and Comparative Example 5 was measured using a fluorometer (manufactured by JASCO Corporation, trade name FT-6500, excitation light 430 nm, high sensitivity). In addition, the transmittance (%) of the aforementioned coating film was measured using an ultraviolet-visible light absorbance photometer.

此外,前述塗佈膜間之發光強度之比較係將波長540nm附近之最大發光強度以下述式(S)-5校正並進行。 In addition, the comparison of the luminous intensity between the aforementioned coating films is performed by correcting the maximum luminous intensity near the wavelength of 540 nm by the following formula (S)-5.

[波長540nm附近之最大發光強度/(100-波長430nm之穿透率)]×100...(S)-5 [Maximum luminous intensity near wavelength 540nm/(100-transmittance at wavelength 430nm)]×100. . . (S)-5

於下述表3及表4記載實施例11至14及比較例4至5之具有鈣鈦礦結構之化合物之溶液製作之構成、最大發光強度。表3及表4中,「M/(M+Pb)」係上述通式(1)中之「a」之饋入比中之值。 In the following Table 3 and Table 4, the constitution and the maximum luminous intensity of the solution prepared of the compound with the perovskite structure of Examples 11 to 14 and Comparative Examples 4 to 5 are described. In Table 3 and Table 4, "M/(M+Pb)" is the value in the feed-in ratio of "a" in the above general formula (1).

Figure 106105503-A0202-12-0030-7
Figure 106105503-A0202-12-0030-7

Figure 106105503-A0202-12-0030-8
Figure 106105503-A0202-12-0030-8

如上述結果所示,應用本實施形態之使用鋇離子作為2價或3價金屬離子之實施例11至13、及使用鏑離子之實施例14之最大發光強度高於未應用本實施 形態之比較例1。 As shown by the above results, the maximum luminous intensity of Examples 11 to 13 using barium ions as divalent or trivalent metal ions and Example 14 using dysprosium ions of this embodiment is higher than that of non-application of this embodiment. Comparative example 1 of morphology.

又,使用2種鹵化物離子(Br及Cl)作為X且應用本實施形態之實施例15之最大發光強度高於未應用本實施形態之比較例4。 In addition, the maximum luminous intensity of Example 15 using two types of halide ions (Br and Cl) as X and applying this embodiment was higher than that of Comparative Example 4 not applying this embodiment.

同樣地,使用2種鹵化物離子(Br及I)作為X且應用本實施形態之實施例16之最大發光強度高於未應用本實施形態之比較例5。 Similarly, the maximum luminous intensity of Example 16 using two types of halide ions (Br and I) as X and applying this embodiment is higher than that of Comparative Example 5 not applying this embodiment.

(產業上之可利用性) (Industrial availability)

依據本實施形態,可提供具有高發光強度之具有鈣鈦礦結構之化合物及含有前述化合物之發光材料。 According to this embodiment, a compound having a perovskite structure with high luminous intensity and a luminescent material containing the aforementioned compound can be provided.

因此,本實施形態之具有鈣鈦礦結構之化合物及使用前述化合物之發光材料可適宜地使用於發光相關材料領域。 Therefore, the compound having the perovskite structure of the present embodiment and the light-emitting material using the aforementioned compound can be suitably used in the field of light-emitting-related materials.

Claims (6)

一種具有鈣鈦礦型結晶結構之化合物,其係以A、B、X、及M為成分,將M之量除以M及B之合計量所得之莫耳比[M/(M+B)]之值為大於0且0.7以下;其中,A係在前述鈣鈦礦型結晶結構中,位於以B為中心之6面體之各頂點之1價陽離子;B係Pb離子;M係2價或3價金屬離子,且係選自在6配位之離子半徑為0.9Å以上1.5Å以下之金屬離子且為鋇離子、鈣離子、鈰離子、鏑離子、鑭離子、釤離子、鍶離子、或鐿離子之陽離子,並且M之至少一部分取代前述鈣鈦礦型結晶結構中B之一部分;X係表示在前述鈣鈦礦型結晶結構中,位於以B為中心之8面體之各頂點之成分,為選自由氯化物離子、溴化物離子、氟化物離子、碘化物離子及硫氰酸根離子所成之群組之1種以上之離子,並且至少含有氯化物離子或溴化物離子作為前述X。 A compound with a perovskite crystal structure, which is composed of A, B, X, and M, and the molar ratio obtained by dividing the amount of M by the total amount of M and B [M/(M+B) ] Is greater than 0 and less than 0.7; where A is a monovalent cation located at each vertex of a hexahedron centered on B in the aforementioned perovskite crystal structure; B is a Pb ion; M is a divalent cation Or trivalent metal ions, and are selected from metal ions with an ionic radius of 0.9 Å or more and 1.5 Å or less in 6 coordination and are barium ions, calcium ions, cerium ions, dysprosium ions, lanthanum ions, samarium ions, strontium ions, or The cation of ytterbium ion, and at least a part of M replaces a part of B in the aforementioned perovskite crystal structure; X represents the component at each vertex of the octahedron centered on B in the aforementioned perovskite crystal structure , Is one or more ions selected from the group consisting of chloride ion, bromide ion, fluoride ion, iodide ion and thiocyanate ion, and contains at least chloride ion or bromide ion as the aforementioned X. 如申請專利範圍第1項所述之化合物,其係下述通式(1)所示者:AB(1-a)MaX(3+δ)(0<a≦0.7,0≦δ≦0.7)…(1)A、B、M、及X係表示與前述相同意義。 The compound described in item 1 of the scope of patent application, which is represented by the following general formula (1): AB (1-a) M a X (3+δ) (0<a≦0.7, 0≦δ≦ 0.7)...(1) A, B, M, and X series have the same meaning as the above. 如申請專利範圍第1項或第2項所述之化合物,其中,前述M係鹼土金屬之離子。 The compound described in item 1 or item 2 of the scope of patent application, wherein the aforementioned M is an ion of alkaline earth metal. 如申請專利範圍第3項所述之化合物,其中,前述M 係鈣離子。 The compound described in item 3 of the scope of patent application, wherein the aforementioned M Department of calcium ions. 如申請專利範圍第1項或第2項所述之化合物,其中,前述A係有機銨離子。 The compound described in item 1 or item 2 of the scope of patent application, wherein the aforementioned A is an organic ammonium ion. 一種發光材料,其係含有申請專利範圍第1項至第5項中任一項所述之化合物。 A luminescent material, which contains the compound described in any one of items 1 to 5 in the scope of the patent application.
TW106105503A 2016-02-19 2017-02-17 Compound having perovskite structure and light emitting material TWI718254B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2016030201 2016-02-19
JP2016-030201 2016-02-19
JP2016126043 2016-06-24
JP2016-126043 2016-06-24

Publications (2)

Publication Number Publication Date
TW201739753A TW201739753A (en) 2017-11-16
TWI718254B true TWI718254B (en) 2021-02-11

Family

ID=59625262

Family Applications (1)

Application Number Title Priority Date Filing Date
TW106105503A TWI718254B (en) 2016-02-19 2017-02-17 Compound having perovskite structure and light emitting material

Country Status (4)

Country Link
JP (1) JP6786582B2 (en)
CN (1) CN108602756B (en)
TW (1) TWI718254B (en)
WO (1) WO2017142089A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6473774B2 (en) * 2016-06-20 2019-02-20 旭化成株式会社 Composition
JP7141047B2 (en) * 2017-02-28 2022-09-22 株式会社小糸製作所 Phosphor
JP7257184B2 (en) * 2019-03-01 2023-04-13 住友化学株式会社 Compositions, films, laminated structures, light-emitting devices and displays
CN111477746B (en) * 2020-04-24 2022-03-04 武汉大学 Low-temperature doped high photoluminescence quantum yield perovskite thin film and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014078392A (en) * 2012-10-10 2014-05-01 Peccell Technologies Inc Electroluminescence element using perovskite compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5882548A (en) * 1997-05-08 1999-03-16 International Business Machines Corporation Luminescent organic-inorganic perovskites with a divalent rare earth metal halide framework

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014078392A (en) * 2012-10-10 2014-05-01 Peccell Technologies Inc Electroluminescence element using perovskite compound

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Fan Zuo et al.,"Binary-Metal Perovskites Toward High-Performance Planar-Heterojunction Hybrid Solar Cells", Adv. Mater., Vol. 26, 2014, page 6454-6460. *

Also Published As

Publication number Publication date
JPWO2017142089A1 (en) 2018-12-06
JP6786582B2 (en) 2020-11-18
TW201739753A (en) 2017-11-16
WO2017142089A1 (en) 2017-08-24
CN108602756B (en) 2021-03-30
CN108602756A (en) 2018-09-28

Similar Documents

Publication Publication Date Title
TWI718254B (en) Compound having perovskite structure and light emitting material
TWI761353B (en) Composition and compound
JP6948168B2 (en) Compounds, dispersion compositions, resin compositions, films, laminated structures and light emitting devices
JP6000839B2 (en) Composite of silicon oxide nanoparticles and silsesquioxane polymer, method for producing the same, and composite material produced using the composite
Li et al. Luminescent hybrid materials of lanthanide β-diketonate and mesoporous host through covalent and ionic bonding with anion metathesis
CN108495951B (en) Multi-solvent perovskite compositions
CN109148737B (en) Precursor, preparation method of perovskite material, solar cell and method for improving stability of perovskite precursor
CN111139068A (en) Zero-dimensional lead-free perovskite Cs3Cu2X5Preparation method and application of
WO2017221837A1 (en) Compound, liquid dispersion composition, and resin composition
Mironov et al. New mixed-ligand cyanohydroxo octahedral cluster complex trans-[Re 6 S 8 (CN) 2 (OH) 4] 4−, its luminescence properties and chemical reactivity
CN110869466B (en) Low-dimensional inorganic/organic hybrid metal halide perovskite
WO2016001219A1 (en) Suspension of a magnesium silicate, method for making same and use thereof as a phosphor
DE102012105782A1 (en) Producing composite material from at least one phosphor and a polymer matrix useful for producing lighting means comprises synthesizing luminescent phosphor nanoparticles in ionic liquid, and polymerizing ionic liquid
WO2016021402A1 (en) Organic-inorganic layered perovskite compound and method for producing organic-inorganic perovskite compound
Grandhi et al. Recent advances and challenges in obtaining stable CsPbX3 (X= Cl, Br, and I) nanocrystals toward white light-emitting applications
Cuan et al. Multi-component assembly and photophysical properties of europium polyoxometalates and polymer functionalized (mesoporous) silica through a double functional ionic liquid linker
DE112012002280B4 (en) Phosphorescent material, its preparation and use
CN107955181B (en) High-stability two-dimensional cationic lead halide material and preparation and application thereof
TWI717527B (en) Composition
WO2023054724A1 (en) Method for preparing copper halide-containing solution, and copper halide-containing solution
KR102162547B1 (en) Chalcogenized organic­inorganic hybrid perovskites compound having Tetravalent Metal ion and Fabrication Method thereof
Jančík et al. Stability Enhancements on Methylammonium Lead‐Based Perovskite Nanoparticles: the Smart Use of Host Matrices
CN116004102A (en) Water-based polyurethane coating with fluorescence characteristic and preparation method thereof
CN109705846A (en) A kind of ion type perfluoro polymer red light material and preparation method and application
Yan Photofunctional Rare Earth Materials Based on Ionic Liquids